Vilas A Gupta

11PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAutoimmunityPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 13, 2023
Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors.

Dennis Juarez, Roberta Buono, Shannon M Matulis

|May 26, 2023
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias.

Ricardo de Matos Simoes, Ryosuke Shirasaki, Sondra L Downey-Kopyscinski

|Sep 28, 2022
Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma.

Aditi Sharma, Remya Nair, Abhinav Achreja

|Mar 19, 2021
BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma.

Vikas A Gupta, James Ackley, Jonathan L Kaufman

Pageof 2